These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 993319)

  • 1. A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1164-9. PubMed ID: 993319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in NSILA-S in response to somatotropin administration and hypophysectomy.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1978 Jul; 47(1):91-6. PubMed ID: 263296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioreceptor assay of insulin-like peptides in human plasma: growth hormone dependence and correlation with sulfation activity by two bioassays.
    Guyda HJ; Corvol MT; Rappaport R; Posner BI
    J Clin Endocrinol Metab; 1979 May; 48(5):739-47. PubMed ID: 429519
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonsuppressible insulin-like activity (NSILA). II. Regulation of serum concentrations by growth hormone and insulin.
    Heinrich UE; Schalch DS; Koch JG; Johnson CJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):672-8. PubMed ID: 573281
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioimmunoassay for non-suppressible insulin-like activity.
    Reber K; Liske R
    Horm Res; 1976; 7(4-5):201-13. PubMed ID: 1017791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-suppressible insulin-like activity in Laron's syndrome.
    Kastrup KW; Zapf J
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):414-20. PubMed ID: 425784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification and characterization of somatomedin from sheep serum.
    Hossner KL; Davis SL; Powell C; Sasser RG
    Endocrinology; 1985 Apr; 116(4):1351-6. PubMed ID: 3971919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of the acid-ethanol soluble component of non-suppressible insulin-like activity in untreated and treated streptozotocin-diabetic rats.
    Franklin RC; Rennie GC; Cameron DP
    J Endocrinol; 1979 Jun; 81(3):331-7. PubMed ID: 469463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the possible mechanism for deficiency of nonsuppressible insulin-like activity in thalassemia major.
    Herington AC; Werther GA; Matthews RN; Burger HG
    J Clin Endocrinol Metab; 1981 Mar; 52(3):393-8. PubMed ID: 6257746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine influences on serum acid-ethanol soluble non-suppressible in insulin-like activity (NSILA-S).
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):127-36. PubMed ID: 6772355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs.
    Schlumpf U; Heimann R; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1976 Jan; 81(1):28-42. PubMed ID: 946140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.
    Megyesi K; Kahn CR; Roth J; Gorden P
    J Clin Endocrinol Metab; 1975 Sep; 41(3):475-84. PubMed ID: 169287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4379-81. PubMed ID: 1069990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSILA and foetal growth.
    Heinrich UE; Schalch DS; Jawadi MH; Johnson CJ
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):534-43. PubMed ID: 425788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels.
    Schalch DS; Heinrich UE; Koch JG; Johnson CJ; Schlueter RJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):664-71. PubMed ID: 755052
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of serum nonsuppressible insulin-like activity (NSILA) in wound healing. I. Influence of thyroparathyroidectomy on serum NSILA and wound healing in the rat.
    Poffenbarger PL; Haberal MA
    Surgery; 1976 Nov; 80(5):608-16. PubMed ID: 982280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of a simple relationship between endogenous growth hormone and NSILA-s related peptides.
    Megyesi K; Gorden P; Kahn R
    J Clin Endocrinol Metab; 1977 Aug; 45(2):330-8. PubMed ID: 885996
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major.
    Werther GA; Matthews RN; Burger HG; Herington AC
    J Clin Endocrinol Metab; 1981 Oct; 53(4):806-9. PubMed ID: 7026588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.